ULS 欢迎您!
ULS 欢迎您!
> 产品中心 > 抑制剂 & 激动剂 > PI3K/Akt/mTOR > PI3K

SAR-260301

Cat. No.:YN420226

  • CAS No. :1260612-13-2

    • 规格

      价格(RMB)

      库存

    • 产品资料
    • 生物活性
    • 参考文献
    • 产品名称: SAR-260301
      CAS No.: 1260612-13-2
      Chemical Name: 2-[2-[(2S)-2,3-dihydro-2-methyl-1H-indol-1-yl]-2-oxoethyl]-6-(4-morpholinyl)-4(3H)-pyrimidinone
      Synonyms:SAR-260301;SAR 260301
      分子量:354.40
      分子式:C₁₉H₂₂N₄O₃
      SMILES:O=C1N=C(CC(N2[C@@H](C)CC3=C2C=CC=C3)=O)NC(N4CCOCC4)=C1
      存储:Please store the product under the recommended conditions in theCertificate of Analysis.
      运输:Room temperature in continental US; may vary elsewhere.
      Select Batch:
      Purity: 98%
    • 产品描述: SAR-260301 是一种有效的,具有口服活性的选择性PI3Kβ抑制剂,IC50为 23 nM。
      IC50和靶点: [{name:"PI3Kβ:23 nM (IC50)"},{name: "PI3Kδ:468 nM (IC50)"},{name: "PI3Kα:1539 nM (IC50)"},{name: "PI3Kγ:10000 nM (IC50)"},{name: "Vps34:183 nM (IC50)"},{name: "PI3KC2γ:3812 nM (IC50)"},{name: "pAkt:49 nM (IC50)"},{name: "DNA-PK:2000 nM (IC50)"}]
      In Vitro:
      In Vivo:
      Clinical Trial:
      Solvent & Solubility:
    • Certal, V., Carry, J.C., Halley, F., et al.Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancersJ. Med. Chem.57(3),903-920(2014)

      Bonnevaux, H., Lemaitre, O., Vincent, L., et al.Concomitant inhibition of PI3Kβ and BRAF or MEK in PTEN-deficient/BRAF-mutant melanoma treatment: Preclinical assessment of SAR260301 oral PI3Kβ-selective inhibitorMol. Cancer Ther.15(7),1460-1471(2016)

    • 摩尔计算器
    • 稀释计算器
    摩尔浓度计算器方程 :
    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    计算

    质量 浓度 体积 分子量
    稀释计算器 :
    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
    • C1
      V1
      C2
      V2
    • 您最近查看的产品:
    相关产品


    ULS 的所有产品和服务仅用于科学研究,我们不为任何其他用途提供产品和服务(也不为任何个人提供产品和服务)Copyright © 2020-2021 ULS. All Rights Reserved. 备案号:粤ICP备2021013238号-1
    0.315703s